Maa: Singapore
Kieli: englanti
Lähde: HSA (Health Sciences Authority)
N(2)-L-ALANYL-L-GLUTAMINE
FRESENIUS KABI (SINGAPORE) PTE LTD
B05XB02
20 g/100ml
INJECTION
N(2)-L-ALANYL-L-GLUTAMINE 20 g/100ml
INTRAVENOUS
Prescription Only
FRESENIUS KABI AUSTRIA GMBH
ACTIVE
1999-10-08
5 6 1 M0xxxxx/xx 111111121211 111111121211 111111121211 111111121211 DIPEPTIVEN ® Qualitative and quantitative composition 100 ml contains: 20 g N(2)-L-alanyl-L-glutamine (= 8.20 g L-alanine, 13.46 g L-glutamine) Water for injections theoretical osmolarity 921 mosmol/l titration acidity 90 - 105 mmol NaOH/l pH value 5.4 - 6.0 Pharmaceutical form Concentrate for solution for infusion Therapeutical indication Dipeptiven ® is indicated as part of an intravenous parenteral nutrition regimen as a supplement to amino acid solutions or an amino acid containing infusion regimen, e.g. in patients in hypercatabolic and/or hypermetabolic states. Posology and method of administration For central venous infusion after addition to a compatible infusion solution. Solutions of mixtures with an osmolarity above 800 mosmol/l should be infused by the central venous route. _Adults_ Dosage depends on the severity of the catabolic state and on amino acid requirement. A maximum daily dosage of 2 g amino acids/kg body weight should not be exceeded in parenteral nutrition. The supply of alanine and glutamine via Dipeptiven ® should be taken into consideration in the calculation. The proportion of the amino acid supplied through Dipeptiven should not exceed approx. 30% of the total amino acid supply. _Daily dose_ 1.5 - 2.5 ml of Dipeptiven per kg body weight (equivalent to 0.3 - 0.5 g N(2)-L-alanyl-L-glutamine per kg body weight). This equates to 100 to 175 ml Dipeptiven for a patient of 70 kg body weight. Reproduction toxicity: In animal trials, no indications of teratogenic or other embryotoxic and peripostnatal injuries could be observed up to a dosage of 1.6 g N(2)-L-alanyl-L-glutamine/kg b.w. per day. Local tolerance: Following repeated i.v. infusion of N(2)-L-alanine- L-glut Lue koko asiakirja
DIPEPTIVEN ® M089414/06 Active substance: N(2)-L-alanyl-L-glutamine QUALITATIVE AND QUANTITATIVE COMPOSITION 100 ml contains: 20 g N(2)-L-alanyl-L-glutamine (= 8.20 g L-alanine, 13.46 g L-glutamine) Water for injections theoretical osmolarity 921 mosmol/l titration acidity 90 - 105 mmol NaOH/l pH value 5.4 - 6.0 PHARMACEUTICAL FORM Concentrate for solution for infusion THERAPEUTICAL INDICATION Dipeptiven ® is indicated as part of an intravenous parenteral nutrition regimen as a supplement to amino acid solutions or an amino acid containing infusion regimen, e.g. in patients in hypercatabolic and/or hypermetabolic states. POSOLOGY AND METHOD OF ADMINISTRATION For central venous infusion after addition to a compatible infusion solution. Solutions of mixtures with an osmolarity above 800 mosmol/l should be infused by the central venous route. _ADULTS _ Dosage depends on the severity of the catabolic state and on amino acid requirement. A maximum daily dosage of 2 g amino acids/kg body weight should not be exceeded in parenteral nutrition. The supply of alanine and glutamine via Dipeptiven ® should be taken into consideration in the calculation. The proportion of the amino acid supplied through Dipeptiven should not exceed approx. 30% of the total amino acid supply. _DAILY DOSE _ 1.5 - 2.5 ml of Dipeptiven per kg body weight (equivalent to 0.3 - 0.5 g N(2)-L-alanyl-L-glutamine per kg body weight). This equates to 100 to 175 ml Dipeptiven for a patient of 70 kg body weight. Maximum daily dose: 2.5 ml equivalent to 0.5 g N(2)-L-alanyl-L-glutamine of Dipeptiven ® per kg body weight. The maximum daily dose of 0.5 g N(2)-L-alanyl-L-glutamine per kg body weight should be administered in combination with a compatible amino acid solution providing at least 1.0 g amino acids per kg body weight and day. This results in a daily dosage of at least 1.5 g amino acids per kg body weight. The following adjustments are examples for the supply with Dipeptiven and other amino acids through the carrier solution: Amino acid requireme Lue koko asiakirja